Previous Close | 7.30 |
Open | N/A |
Bid | 2.15 |
Ask | 5.40 |
Strike | 300.00 |
Expire Date | 2024-11-15 |
Day's Range | 7.30 - 7.30 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
On May 10, 2024, Joseph Laplume, Executive Vice President of Corporate Strategy & Development, sold 1,304 shares of Charles River Laboratories International Inc (NYSE:CRL).
Explore Charles River's (CRL) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.